Transforming Nuclear Medicine
Solixia is an early-stage life science company pioneering the use of radioactivity in medicine. Our goal is to harness the unrealized potential of radioactivity to detect and treat severe, systemic, or late-stage disease. We will achieve this by developing and commercializing innovative, radioactive molecules that can deliver large amounts of diagnostic or therapeutic radiation specifically to target organs or tissues.
The focus of our lead research program is a treatment for chemorefractory ovarian cancer.